Cancer Immunotherapy Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook
Cancer Immunotherapy Market Segmentation, By Product Type (Checkpoint Inhibitors, Monoclonal Antibodies, Vaccines, Cell Therapies, Immunomodulators and Oncolytic Virus), Application (Lung Cancer, Breast Cancer, Melanoma, Multiple Myeloma, Prostate Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Colorectal Cancer, Head & Neck Cancer, and Others), End User (Hospitals, Oncology Clinics, Homecare, and Others), Form (Intravenous (IV), Intramuscular, and Oral), Distribution Channel (Direct Tenders, Retail Sales, and Pharmacies) - Industry Trends and Forecast to 2032 Cancer Immunotherapy Market Size The global cancer immunotherapy market size was valued at USD 95.69 billion in 2024 and is expected to reach USD 28.27 billion by 2032 , at a CAGR of 15.50% during the forecast period This growth is driven by factors such as the increasing prevalence of cancer worldwide, advancements in immunotherapy technologies, rising investments...